PIMA515328

BRK Monoclonal Antibody (2H12B8), Invitrogen™

Manufacturer: Thermo Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 PIMA515328-Each-of-1 In Stock ₹ 52,198.50

PIMA515328 - Each of 1

₹ 52,198.50

In Stock

Quantity

1

Base Price: ₹ 52,198.50

GST (18%): ₹ 9,395.73

Total Price: ₹ 61,594.23

Antigen

BRK

Classification

Monoclonal

Concentration

Conc. Not Determined

Formulation

ascites with 0.03% sodium azide

Gene Accession No.

Q13882

Gene Symbols

PTK6

Immunogen

Purified recombinant fragment of human PTK6 expressed in E. Coli.

Regulatory Status

RUO

Gene ID (Entrez)

5753

Content And Storage

Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.

Form

Liquid

Applications

ELISA, Western Blot

Clone

2H12B8

Conjugate

Unconjugated

Gene

PTK6

Gene Alias

ALT-PTK6; breast tumor kinase; BRK; deltam5; FLJ42088; protein tyrosine kinase 6; protein-tyrosine kinase 6; protein-tyrosine kinase BRK; Ptk6; PTK6 protein tyrosine kinase 6; Sik; SRC-related intestinal kinase; tks; Tksk; tyrosine kinase identified from skin; tyrosine-protein kinase BRK

Host Species

Mouse

Quantity

100 μL

Primary or Secondary

Primary

Target Species

Human

Product Type

Antibody

Isotype

IgG2b

Related Products

Img

Thermo Scientific

PIMA515669

--

Img

Thermo Scientific

PIMA515707

--

Img

Thermo Scientific

PIMA515634

--

Img

Thermo Scientific

PIMA515505

--

Img

Thermo Scientific

PIMA515414

--

Img

Thermo Scientific

PIMA515340

--

Img

Thermo Scientific

PIMA515298

--

Img

Thermo Scientific

PIMA515448

--

Description

  • MA5-15328 targets PTK6 in indirect ELISA, WB applications and shows reactivity with Human samples
  • The MA5-15328 immunogen is purified recombinant fragment of human PTK6 expressed in E
  • Coli
  • MA5-15328 detects PTK6 which has a predicted molecular weight of approximately 52kDa
  • Breast tumor kinase (Brk) is a non-receptor protein tyrosine kinase expressed in over 60% of breast carcinoma tissue samples and breast tumor cell lines
  • Brk is 80% identity to Sik (Src-related intestinal kinase) and exhibits the features of a novel non-receptor tyrosine kinase, including amino terminal SH3 and SH2 domains
  • Low levels of Brk transcripts have been identified in some human breast tumor cell lines but not in normal breast tissue.